Seqstant GmbH is a German startup founded in 2021 with the slogan "Die Lösung für metagenomische Diagnostik in Echtzeit" (The solution for real-time metagenomic diagnostics). The company provides the LiveGene platform for live analysis of pathogens, enabling sensitive, specific, and user-friendly genetic real-time diagnostics. SEQSTANT automates the analysis process and ensures interoperability for NGS analytics in a single solution. Their description emphasizes simplicity for users, stating "Einfach den Lauf starten, den Rest machen wir!" (Simply start the run, and we'll take care of the rest).
In November 5, 2023, Seqstant GmbH secured a €1.80M Seed Round investment from BC Brandenburg Capital, HPI SEED, Venture League, Saarbruecker 21. The last investment underscores the confidence of these investors in Seqstant's innovative approach in the Information Technology industry.